The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 5,301–5,400 of 31,469
Chan, D. C., Barrett, P. H. R., Ooi, E. M. M., Ji, J., Chan, D. T., & Watts, G. F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1457 · Cited by 69
CBT-506, O. B. O., Toussirot, É., Mourot, L., Dehecq, B., Wendling, D., Grandclément, É., & Dumoulin, G. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0599-2 · Cited by 66
Association between thyroid hormones and body fat in euthyroid subjects
Ren, R., Jiang, X., Zhang, X., Guan, Q., Yu, C., Li, Y.-Z., Gao, L., Zhang, H., & Zhao, J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12311 · Cited by 66
Association between urinary cadmium levels and prediabetes in the NHANES 2005–2010 population
Wallia, A., Allen, N. B., Badon, S. E., & Muayed, M. E. (2014) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2014.06.005 · Cited by 70
Fortier, M., Hogg, W. E., O’Sullivan, T. L., Blanchard, C., Reid, R. D., Sigal, R. J., Boulay, P., Doucet, É., Sweet, S. N., Bisson, E. J., et al. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-075 · Cited by 71
Kim, J.-W., & Kim, D. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0036 · Cited by 67
Wang, J., Lin, S.-D., Lee, W., Su, S., Lee, I., Tu, S., Tseng, Y., Lin, S., & Sheu, W. H. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.10.014 · Cited by 68
Sharma, A. K., & Srinivasan, B. P. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.09.004 · Cited by 66
Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats
Mahmoud, A. A. A., & Elshazly, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106993 · Cited by 66
Arbonés-Mainar, J. M., Ross, K., Rucklidge, G. J., Reid, M., Duncan, G., Arthur, J. R., Horgan, G. W., Navarro, M. Á., Carnicer, R., Arnal, C., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070321a · Cited by 66
MacEneaney, O. J., Harrison, M., O’Gorman, D. J., Pankratieva, E., O’Connor, P. L., & Moyna, N. M. (2009) · European Journal of Applied Physiology · doi:10.1007/s00421-009-1073-y · Cited by 66
Cabrera, E. J., Valezi, A. C., Delfino, V. D. A., Lavado, E. L., & Barbosa, D. S. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9988-2 · Cited by 66
Exercise Reduces Inflammation and Oxidative Stress in Obesity-Related Liver Diseases
Oh, S., Tanaka, K., Warabi, E., & Shoda, J. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31829afc33 · Cited by 67
Papandreou, D., Karabouta, Z., Pantoleon, A., & Rousso, I. (2012) · Appetite · doi:10.1016/j.appet.2012.09.006 · Cited by 66
Cupisti, S., Häberle, L., Dittrich, R., Oppelt, P. G., Reissmann, C., Kronawitter, D., Beckmann, M. W., & Mueller, A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.062 · Cited by 65
Usui, C., Asaka, M., Kawano, H., Aoyama, T., Ishijima, T., Sakamoto, S., & Higuchi, M. (2010) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.56.109 · Cited by 72
Lin, W.-Y., Yang, W.-S., Lee, L.-T., Chen, C.-Y., Liu, C.-S., Lin, C., & Huang, K.-C. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803240 · Cited by 67
Choi, S. H., Kwak, S. H., Youn, B., Lim, S. K., Park, Y. J., Lee, H., Lee, N., Cho, Y. M., Lee, H. K., Kim, Y., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1755 · Cited by 65
Central Obesity, Leptin and Cognitive Decline: The Sacramento Area Latino Study on Aging
Hazzouri, A. Z. A., Haan, M. N., Whitmer, R. A., Yaffe, K. S., & Neuhaus, J. M. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000339957 · Cited by 68
Seo, J., Song, S.-W., Han, K., Lee, K.-J., & Kim, H.-N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105990 · Cited by 66
Dietary total antioxidant capacity and obesity in children and adolescents
Puchau, B., Ochoa, M. C., Zulet, M. Á., Martí, A., Martínez, J. A., & Members, G. (2010) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637481003757860 · Cited by 65
Tuna, M. M., İmga, N. N., Dogan, B. A., Yılmaz, F. M., Topçuoğlu, C., Akbaba, G., Berker, D. S., & Güler, S. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0106-5 · Cited by 66
Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females
Savastano, S., Somma, C. D., Pizza, G., Rosa, A. D., Nedi, V., Rossi, A., Orio, F., Lombardi, G., Colao, A., & Tarantino, G. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-136 · Cited by 66
Petersson, U., Östgren, C. J., Brudin, L. H., Brismar, K., & Nilsson, P. M. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.11.003 · Cited by 66
Derosa, G., Fogari, E., D’Angelo, A., Cicero, A. F. G., SALVADEO, S. A. T., Ragonesi, P. D., Ferrari, I., Gravina, A., Fassi, R., & Fogari, R. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00820.x · Cited by 66
HOMA or QUICKI: Is it useful to test the reproducibility of formulas?
Antuna-Puente, B., Faraj, M., Karelis, A. D., Garrel, D. R., Prud’homme, D., RABASA-LHORET, R. P. R., & Bastard, J. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.02.001 · Cited by 68
Crochemore, I. C. C., Souza, A. F. P., de Souza, A. C. F., & Rosado, E. L. (2012) · Nutrition in Clinical Practice · doi:10.1177/0884533612444535 · Cited by 66
Disorders of Glucose Metabolism among HIV-Infected Women
Howard, A. A., Floris-Moore, M., Arnsten, J. H., Santoro, N. F., Fleischer, N. L., Lo, Y., & Schoenbaum, E. E. (2005) · Clinical Infectious Diseases · doi:10.1086/429824 · Cited by 66
Osorio-Conles, Ó., Guitart, M., Chacón, M. R., Maymó‐Masip, E., Moreno‐Navarrete, J. M., Montori-Grau, M., Näf, S., Fernández‐Real, J. M., Vendrell, J. J., & Gómez-Foix, A. M. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00163.2011 · Cited by 67
Giménez‐Palop, O., Giménez‐Pérez, G., Mauricio, D., Berlanga, E., Potau, N., Vilardell, C., Arroyo, J., González-Clemente, J. M., & Caixàs, A. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01934 · Cited by 66
Douglass, J. D., Zhou, Y. X., Wu, A., Zadrogra, J. A., Gajda, A. M., Lackey, A. I., Lang, W., Chevalier, K. M., Sutton, S. W., Zhang, S., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m058586 · Cited by 71
Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection
Longenecker, C. T., Sattar, A., Gilkeson, R., & McComsey, G. A. (2016) · AIDS · doi:10.1097/qad.0000000000001167 · Cited by 66
Mirmiran, P., Esfandyari, S., Bahadoran, Z., Tohidi, M., & Azizi, F. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-016-0247-5 · Cited by 67
Huh, J. H., Kim, J., Choi, E. H., Kim, J. S., Chang, Y., & Sung, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180951 · Cited by 67
Okoduwa, S. I. R., Umar, I., James, D. B., & Inuwa, H. M. (2017) · Medicines · doi:10.3390/medicines4040073 · Cited by 69
Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels
Rana, K. S., Pararasa, C., Afzal, I., Nagel, D. A., Hill, E. J., Bailey, C. J., Griffiths, H. R., Kyrou, I., Randeva, H. S., Bellary, S., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0627-2 · Cited by 67
Cigarette smoking and thyroid cancer risk: a cohort study
Cho, A., Chang, Y., Ahn, J., Shin, H. C., & Ryu, S. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0224-5 · Cited by 66
Chen, L., Chien, C.-Y., Yang, K.-J., Kuo, S., Chen, C., & Chien, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128671 · Cited by 69
Yu, H., Yang, Y., Zhang, M., Lü, H., Zhang, J., Wang, H., & Cianflone, K. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-13 · Cited by 66
Yates, A. P., & Laing, I. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00644.x · Cited by 66
Prevalence and characteristics of early-onset type 2 diabetes in Mexico
Aguilar-Salinas, C. A., Rojas, R., Gomez-Perez, F. J., Garcı́a, E., Valles, V., Rı́os-Torres, J. M., Franco, A., Oláiz, G., Sepúlveda, J., & Rull, J. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01314-1 · Cited by 66
Gill, J. M. R., CASLAKE, M. J., McAllister, C. J., Tsofliou, F., Ferrell, W. R., Packard, C. J., & Malkova, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030226 · Cited by 69
Malmqvist, K. K., Öhman, K. P., Lind, L., Nyström, F. H., & Kahan, T. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01053.x · Cited by 65
Obesity in Spanish Schoolchildren: Relationship with Lipid Profile and Insulin Resistance
Garcés, C., Gutiérrez-Guisado, J., Benavente, M., Cano, B., Viturro, E., Ortega, H., & de Oya, M. (2005) · Obesity Research · doi:10.1038/oby.2005.111 · Cited by 66
Mimoun, E., Aggoun, Y., Pousset, M., Dubern, B., Bouglé, D. L., Girardet, J.-P., Basdevant, A., Bonnet, D., & Tounian, P. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.12.048 · Cited by 66
Takase, H., Shoji, K., Hase, T., & Tokimitsu, I. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.11.020 · Cited by 66
Sánchez-Hernández, J., Ybarra, J., Gich, I. J., de Leiva, A., Ríus, X., Rodrı́guez-Espinosa, J., & Pérez, A. (2005) · Obesity Surgery · doi:10.1381/096089205774859182 · Cited by 66
Grarup, N., Andersen, M. K., Andreasen, C. H., Albrechtsen, A., Borch-Johnsen, K., Jørgensen, T., Auwerx, J. H., Schmitz, O., Hansen, T. F., & Pedersen, O. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1958 · Cited by 66
Choi, K. M., Lee, J., Kim, Y. H., Kim, K. B., Kim, D. L., Kim, S. G., Shin, D. H., Kim, N. H., Park, I. B., Choi, D. S., et al. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00059-7 · Cited by 65
Ng, M. C. Y., Miyake, K., So, W. Y., Poon, E. W. M., Lam, V. K. L., Li, J. K. Y., Cox, N. J., Bell, G. I., & Chan, J. C. N. (2005) · Diabetologia · doi:10.1007/s00125-005-1914-0 · Cited by 66
Fraser, A., Ebrahim, S. B. J., Smith, G. D., & Lawlor, D. A. (2007) · Hepatology · doi:10.1002/hep.21667 · Cited by 66
Increased insulin sensitivity in patients with anorexia nervosa: the role of adipocytokines
Dostálová, I., Smitka, K., Papežová, H., Kvasničková, H., & Nedvidkova, J. (2007) · Physiological Research · doi:10.33549/physiolres.931089 · Cited by 65
Hedblad, B., Zambanini, A., Nilsson, P. M., Janzon, L., & Berglund, G. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01767.x · Cited by 66
Weaver, J. U., Taylor, N., Monson, J. P., Wood, P. J., & Kelly, W. F. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00494.x · Cited by 66
Han, T. S., Conway, G. S., Willis, D. S., Krone, N., Rees, D. A., Stimson, R. H., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), T. U. K. C. A. H. A. S. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1486 · Cited by 65
Impaired Insulin Secretion in Four Tangier Disease Patients with ABCA1 Mutations
Koseki, M., Matsuyama, A., Nakatani, K., Inagaki, M., Nakaoka, H., Kawase, R., Yuasa-Kawase, M., Tsubakio-Yamamoto, K., Masuda, D., C. Sandoval, J., et al. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e599 · Cited by 65
San Millán, J. L., Botella-Carretero, J. I., Álvarez-Blasco, F., Luque-Ramírez, M., Sancho, J., Moghetti, P., & Escobar-Morreale, H. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1523 · Cited by 65
Triglyceride–Glucose Index as a Potential Indicator of Sarcopenic Obesity in Older People
Kim, B., Kim, G., Lee, Y., Taniguchi, K., Isobe, T., & Oh, S. (2023) · Nutrients · doi:10.3390/nu15030555 · Cited by 65
“The homeostasis model assessment of insulin resistance (HOMA-IR) has been used for many years to evaluate insulin sensitivity in clinical practice [14].”
MethodKrebs, J. D., Bell, D., Hall, R., Parry-Strong, A., Docherty, P. D., Clarke, K., & Chase, J. G. (2013) · Journal of the American College of Nutrition · doi:10.1080/07315724.2013.767630 · Cited by 65
EL-Mesallamy, H. O., Hamdy, N. Μ., Zaghloul, A. S., & Sallam, A.-A. M. (2012) · Pancreas · doi:10.1097/mpa.0b013e3182550d9d · Cited by 65
Marchal, J., Blanc, S., Epelbaum, J., Aujard, F., & Pifferi, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034289 · Cited by 65
Ban, B., Bai, B., Zhang, M., Hu, J., Ramanjaneya, M., Tan, B. K., & Chen, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112931 · Cited by 65
El-Derany, M. O., Hamdy, N. Μ., Al-Ansari, N. L., & EL-Mesallamy, H. O. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0440-5 · Cited by 66
El-Haleim, E. A. A., Bahgat, A. K., & Saleh, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i10.2931 · Cited by 68
Chirakalwasan, N., Amnakkittikul, S., Wanitcharoenkul, E., Charoensri, S., Saetung, S., Chanprasertyothin, S., Chailurkit, L., Panburana, P., Bumrungphuet, S., Thakkinstian, A., et al. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6972 · Cited by 70
Effects of Two-Week Sleep Extension on Glucose Metabolism in Chronically Sleep-Deprived Individuals
So-ngern, A., Chirakalwasan, N., Saetung, S., Chanprasertyothin, S., Thakkinstian, A., & Reutrakul, S. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7758 · Cited by 69
Nie, X., Ma, X., Xu, Y., Shen, Y., Wang, Y., & Bao, Y. (2020) · Thyroid · doi:10.1089/thy.2020.0011 · Cited by 64
Coelho, M. D. F. R., Monteyne, A. J., Dirks, M. L., Finnigan, T. J. A., Stephens, F. B., & Wall, B. T. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520002524 · Cited by 70
Summers, N. A., Lahiri, C. D., Angert, C. D., Aldredge, A., Mehta, C. C., Ofotokun, I., Kerchberger, A. M., Gustafson, D., Weiser, S. D., Kassaye, S., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002447 · Cited by 67
Othman, M. S., Khaled, A. M., Al-Bagawi, A. H., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112287 · Cited by 65
Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China
Huang, R., Cheng, Z., Jin, X., Yu, X., Yu, J., Guo, Y., Zong, L., Sheng, J., Liu, X., & Wang, S. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2039956 · Cited by 65
Kim, Y., Lim, J. H., Kim, E. N., Hong, Y. A., Park, H., Chung, S., Choi, B. S., Kim, Y., Park, J. Y., Kim, H. W., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04726-8 · Cited by 68
Mashayekhi, M., Nian, H., Mayfield, D., Devin, J. K., Gamboa, J. L., Yu, C., Silver, H. J., Niswender, K. D., Luther, J. M., & Brown, N. J. (2023) · Diabetes · doi:10.2337/db23-0356 · Cited by 74
Miller, T., Borkowsky, W., DiMeglio, L. A., Dooley, L. B., Geffner, M. E., Hazra, R., McFarland, E., Mendez, A. J., Patel, K., Siberry, G. K., et al. (2011) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00970.x · Cited by 65
Verrijken, A., Beckers, S., Francque, S., Hilden, H., Caron, S., Zegers, D., Ruppert, M., Hubens, G., Marck, E. V., Michielsen, P. P., et al. (2013) · Obesity · doi:10.1002/oby.20366 · Cited by 71
Chronic hepatitis C infection is associated with insulin resistance and lipid profiles
Dai, C., Yeh, M., Huang, C., et al. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12313 · Cited by 65
Bastard, J., Lavoie, M.-È., Messier, V., Prud’homme, D., & RABASA-LHORET, R. P. R. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.01.004 · Cited by 67
Dagogo-Jack, S. E., Edeoga, C., Ebenibo, S., Nyenwe, E. A., & Wan, J. Y. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1077 · Cited by 68
Thomsen, K. L., Grønbæk, H., Glavind, E., Hebbard, L., Jessen, N., Clouston, A. D., George, J., & Vilstrup, H. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00036.2014 · Cited by 66
Reverri, E. J., LaSalle, C., Franke, A. A., & Steinberg, F. M. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400270 · Cited by 65
Anan, F., Takahashi, N., Nakagawa, M., Ooie, T., Saikawa, T., & Yoshimatsu, H. (2005) · Metabolism · doi:10.1016/j.metabol.2004.11.012 · Cited by 65
van Donkelaar, E. L., Vaessen, K. R. D., Pawluski, J. L., Sierksma, A. S. R., Blokland, A., Cañete, R., & Steinbusch, H. W. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106960 · Cited by 73
Yoshizaki, T., Tada, Y., Hida, A., Sunami, A., Yokoyama, Y., Yasuda, J., Nakai, A., Togo, F., & Kawano, Y. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2702-z · Cited by 65
Perreault, M., Zulyniak, M. A., Badoud, F., Stephenson, S., Badawi, A. F., Buchholz, A. C., & Mutch, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088539 · Cited by 68
Ashley, D. T., O'Sullivan, E. P., Davenport, C., Devlin, N. F. C., Crowley, R. K., McCaffrey, N., Moyna, N. M., Smith, D., & O’Gorman, D. J. (2010) · Metabolism · doi:10.1016/j.metabol.2010.10.001 · Cited by 65
Singh, G. K., Vitola, B. E., Holland, M. R., Sekarski, T. J., Patterson, B. W., Magkos, F., & Klein, S. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.11.024 · Cited by 65
Han, S. H., Choi, S. H., Cho, B. J., Lee, Y., Lim, S. K., Park, Y. J., Moon, M. K., Lee, H. K., Kang, S., Han, D. S., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2010.03.018 · Cited by 65
Iannuzzi, A., Licenziati, M. R., Vacca, M., Marco, D. D., Cinquegrana, G., Laccetti, M., Bresciani, A., Covetti, G., Iannuzzo, G., Rubba, P., et al. (2009) · Heart and Vessels · doi:10.1007/s00380-008-1138-6 · Cited by 64
Barbieri, M., Paolisso, G., Kimura, M., Gardner, J. P., Boccardi, V., Papa, M., Hjelmborg, J., Christensen, K., Brimacombe, M. B., Nawrot, T. S., et al. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.10.002 · Cited by 66
Naja, F., Nasreddine, L., Hwalla, N. C., Moghames, P., Shoaib, H., Fatfat, M., Sibai, A. M., & Gali‐Muhtasib, H. U. (2012) · Helicobacter · doi:10.1111/j.1523-5378.2012.00970.x · Cited by 65
Gender Dimorphism in Aspartame-Induced Impairment of Spatial Cognition and Insulin Sensitivity
Collison, K. S., Makhoul, N. J., Zaidi, M. Z., Saleh, S. M., Andres, B. L., Inglis, A. L., Al‐Rabiah, R. K., & Al-Mohanna, F. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031570 · Cited by 65
Pardina, E., Ferrer, R., Baena‐Fustegueras, J. A., Lecube, A., Fort, J. M., Vargas, V., Catalán, R., & Peinado‐Onsurbe, J. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0103-5 · Cited by 64
Kanagasabapathy, G., Kuppusamy, U. R., Malek, S. N. A., Abdulla, M. A., Chua, K. H., & Sabaratnam, V. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-261 · Cited by 68
Maternal High-Fat Diet Programs for Metabolic Disturbances in Offspring despite Leptin Sensitivity
Volpato, A. M., Schultz, A., Magalhães-da-Costa, E., Correia, M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2012) · Neuroendocrinology · doi:10.1159/000336377 · Cited by 71
Self-rated health as a comprehensive indicator of lifestyle-related health status
Yamada, C., Moriyama, K., & Takahashi, E. (2012) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-012-0274-x · Cited by 65
Risk factors for cardiovascular disease in patients with subclinical hypothyroidism
Törüner, F. B., Altınova, A. E., Karakoç, A., Yetkin, İ., Ayvaz, G., Çakır, N., & Arslan, M. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0053-7 · Cited by 66
The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease
Fava, A., Pirritano, D., Plastino, M., Cristiano, D., Puccio, G., Colica, C., Ermio, C., Bartolo, M. D., Mauro, G. F., & Bosco, D. (2013) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/454253 · Cited by 67
Comparative evaluation of simple indices of insulin resistance
Vaccaro, O., Masulli, M., Cuomo, V., Rivellese, A. A., Uusitupa, M. I. J., Vessby, B. O., Hermansen, K., Tapsell, L. C., & Riccardi, G. (2004) · Metabolism · doi:10.1016/j.metabol.2004.05.017 · Cited by 66
Sierra-Laguado, J., Garcia, R. G., Celedon, J. C., Arenas-Mantilla, M., Pradilla, L. P., Camacho, P. A., & López-Jaramillo, P. A. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.10.009 · Cited by 65
Pražnikar, Z. J., Petelin, A., Jurdana, M., & Žiberna, L. (2013) · Metabolism · doi:10.1016/j.metabol.2013.01.011 · Cited by 65
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
